Published on 18 Oct 2024 on GuruFocus.com · via Yahoo Finance
Overview of the Recent Transaction
State Street Corp, a prominent investment firm, recently expanded its portfolio by acquiring 13,201,978 shares in Iovance Biotherapeutics Inc (NASDAQ:IOVA). This transaction, which took place on September 30, 2024, signifies a notable addition strategy by the firm, reflecting a bullish stance on the biotechnology sector. The shares were purchased at a price of $9.39, marking a significant investment in the clinical-stage biopharmaceutical company.
Profile of State Street Corp